These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 14739713)

  • 1. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM
    Card Electrophysiol Rev; 2003 Sep; 7(3):201-7. PubMed ID: 14739713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM;
    Heart; 2002 Oct; 88(4):357-62. PubMed ID: 12231591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial.
    Williams ES; Thompson VP; Chiswell KE; Alexander JH; White HD; Ohman EM; Al-Khatib SM
    Cardiol J; 2013; 20(4):439-46. PubMed ID: 23913464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN; Tang XC; Reda D; Singh BN
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of recurrences of new atrial fibrillation in acute myocardial infarction.
    Asanin M; Perunicic J; Mrdovic I; Matic M; Vujisic-Tesic B; Arandjelovic A; Vojvodic A; Marinkovic J; Ostojic M; Vasiljevic Z
    Int J Cardiol; 2006 May; 109(2):235-40. PubMed ID: 16005995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
    Kosior D; Opolski G; Torbicki A
    Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
    Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey.
    Pisters R; Nieuwlaat R; Prins MH; Le Heuzey JY; Maggioni AP; Camm AJ; Crijns HJ;
    Europace; 2012 May; 14(5):666-74. PubMed ID: 22223715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up.
    Berton G; Cordiano R; Cucchini F; Cavuto F; Pellegrinet M; Palatini P
    Int J Clin Pract; 2009 May; 63(5):712-21. PubMed ID: 19392921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitating electrical cardioversion of persistant atrial fibrillation by antiarrhythmic drugs: update on clinical trial results.
    Sung RJ
    Card Electrophysiol Rev; 2003 Sep; 7(3):300-3. PubMed ID: 14739733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone and mortality among elderly patients with acute myocardial infarction with atrial fibrillation.
    Kilborn MJ; Rathore SS; Gersh BJ; Oetgen WJ; Solomon AJ
    Am Heart J; 2002 Dec; 144(6):1095-101. PubMed ID: 12486436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.
    Schilling RJ
    Heart; 2010 Mar; 96(5):333-8. PubMed ID: 19910286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
    J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.